RAPID NUTRITION PLC (ALRPD.PA)

GB00BM9PTW47 - Common Stock

0.0372  +0 (+3.33%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALRPD. ALRPD was compared to 58 industry peers in the Food Products industry. ALRPD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALRPD does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

In the past year ALRPD has reported negative net income.
ALRPD had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ALRPD reported negative net income in multiple years.
In the past 5 years ALRPD always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -287.36%, ALRPD is doing worse than 98.25% of the companies in the same industry.
With a Return On Equity value of -414.45%, ALRPD is not doing good in the industry: 96.49% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -287.36%
ROE -414.45%
ROIC N/A
ROA(3y)-203.72%
ROA(5y)-165.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of ALRPD (29.29%) is worse than 66.67% of its industry peers.
ALRPD's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALRPD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.3%
GM growth 5Y-25.51%

5

2. Health

2.1 Basic Checks

ALRPD has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALRPD has more shares outstanding
ALRPD has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -36.50, we must say that ALRPD is in the distress zone and has some risk of bankruptcy.
ALRPD has a worse Altman-Z score (-36.50) than 96.49% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that ALRPD is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.10, ALRPD belongs to the best of the industry, outperforming 94.74% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z -36.5
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 3.49 indicates that ALRPD has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.49, ALRPD belongs to the top of the industry, outperforming 87.72% of the companies in the same industry.
ALRPD has a Quick Ratio of 2.75. This indicates that ALRPD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.75, ALRPD belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.49
Quick Ratio 2.75

1

3. Growth

3.1 Past

ALRPD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -158.70%.
ALRPD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -43.89%.
Measured over the past years, ALRPD shows a very negative growth in Revenue. The Revenue has been decreasing by -16.78% on average per year.
EPS 1Y (TTM)-158.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-43.89%
Revenue growth 3Y-23.38%
Revenue growth 5Y-16.78%
Sales Q2Q%4.62%

3.2 Future

The Earnings Per Share is expected to decrease by -55.42% on average over the next years. This is quite bad
Based on estimates for the next years, ALRPD will show a very negative growth in Revenue. The Revenue will decrease by -10.49% on average per year.
EPS Next Y-100%
EPS Next 2Y-41.42%
EPS Next 3Y-25.99%
EPS Next 5Y-55.42%
Revenue Next Year-50.1%
Revenue Next 2Y-26.78%
Revenue Next 3Y-15.84%
Revenue Next 5Y-10.49%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

ALRPD's earnings are expected to decrease with -25.99% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.42%
EPS Next 3Y-25.99%

0

5. Dividend

5.1 Amount

No dividends for ALRPD!.
Industry RankSector Rank
Dividend Yield N/A

RAPID NUTRITION PLC

EPA:ALRPD (9/13/2024, 7:00:00 PM)

0.0372

+0 (+3.33%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.21K
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -287.36%
ROE -414.45%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 29.29%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.49
Quick Ratio 2.75
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-158.7%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-100%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-43.89%
Revenue growth 3Y-23.38%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y